Jürgen Moll

4.0k total citations
41 papers, 1.2k citations indexed

About

Jürgen Moll is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Jürgen Moll has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Cell Biology and 16 papers in Oncology. Recurrent topics in Jürgen Moll's work include Proteoglycans and glycosaminoglycans research (16 papers), Glycosylation and Glycoproteins Research (15 papers) and Immunotherapy and Immune Responses (7 papers). Jürgen Moll is often cited by papers focused on Proteoglycans and glycosaminoglycans research (16 papers), Glycosylation and Glycoproteins Research (15 papers) and Immunotherapy and Immune Responses (7 papers). Jürgen Moll collaborates with scholars based in Germany, Austria and France. Jürgen Moll's co-authors include Peter Herrlich, Helmut Ponta, Jonathan P. Sleeman, Martin Hofmann‐Apitius, Gilles Sansig, Andrew C.B. Cato, W. Rudy, Sophia K. Khaldoyanidi, Elena Fattori and Larry S. Sherman and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Cell Biology.

In The Last Decade

Jürgen Moll

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jürgen Moll Germany	20	787	586	285	230	171	41	1.2k
Anna Maria Curatola United States	11	971 1.2×	429 0.7×	266 0.9×	378 1.6×	128 0.7×	18	1.4k
Samuel Godár Austria	10	781 1.0×	329 0.6×	491 1.7×	317 1.4×	330 1.9×	11	1.5k
Dvorah Ish‐Shalom Israel	10	794 1.0×	437 0.7×	296 1.0×	238 1.0×	96 0.6×	12	1.2k
Jason J. Zoeller United States	15	619 0.8×	370 0.6×	205 0.7×	183 0.8×	192 1.1×	23	1.1k
Marie Schoumacher France	13	605 0.8×	601 1.0×	428 1.5×	193 0.8×	168 1.0×	16	1.3k
DeannaLee M. Beauvais United States	10	679 0.9×	782 1.3×	156 0.5×	407 1.8×	90 0.5×	13	1.2k
Volker Assmann Germany	13	768 1.0×	443 0.8×	487 1.7×	133 0.6×	192 1.1×	15	1.2k
Ilaria Cascone France	20	937 1.2×	287 0.5×	450 1.6×	174 0.8×	214 1.3×	42	1.5k
Jerry E. Stewart United States	20	783 1.0×	297 0.5×	317 1.1×	384 1.7×	99 0.6×	66	1.2k
Robert W. Tilghman United States	11	658 0.8×	786 1.3×	413 1.4×	685 3.0×	190 1.1×	11	1.6k

Countries citing papers authored by Jürgen Moll

Since Specialization

Citations

This map shows the geographic impact of Jürgen Moll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Moll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Moll more than expected).

Fields of papers citing papers by Jürgen Moll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Moll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Moll. The network helps show where Jürgen Moll may publish in the future.

Co-authorship network of co-authors of Jürgen Moll

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Moll. A scholar is included among the top collaborators of Jürgen Moll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Moll. Jürgen Moll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calvet, Loreley, Emmanuel Spanakis, Jean-Christophe Le Bail, et al.. (2022). YAP1 is essential for malignant mesothelioma tumor maintenance. BMC Cancer. 22(1). 639–639. 12 indexed citations

Rudolph, Dorothea, Andreas Gollner, Sophia M. Blake, et al.. (2018). Abstract 4868: BI 907828: A novel, potent MDM2 inhibitor that is suitable for high-dose intermittent schedules. Cancer Research. 78(13_Supplement). 4868–4868. 4 indexed citations

Sanderson, Michael P., Marco H. Hofmann, Pilar Garin‐Chesa, et al.. (2017). The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy. Molecular Cancer Therapeutics. 16(10). 2223–2233. 22 indexed citations

Li, Huaibiao, Torsten Kroll, Jürgen Moll, et al.. (2017). Spindle Misorientation of Cerebral and Cerebellar Progenitors Is a Mechanistic Cause of Megalencephaly. Stem Cell Reports. 9(4). 1071–1080. 18 indexed citations

Li, Huaibiao, Lucien Frappart, Jürgen Moll, et al.. (2016). Impaired Planar Germ Cell Division in the Testis, Caused by Dissociation of RHAMM from the Spindle, Results in Hypofertility and Seminoma. Cancer Research. 76(21). 6382–6395. 28 indexed citations

Neeb, Antje, Natalia Novac, P. Schlag, et al.. (2011). The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patients. Oncogene. 31(33). 3796–3806. 40 indexed citations

Thiele, Wilko, Natalia Novac, Sigrun Mink, et al.. (2011). Discovery of a novel tumour metastasis‐promoting gene, NVM‐1. The Journal of Pathology. 225(1). 96–105. 12 indexed citations

Sleeman, Jonathan P., Jürgen Moll, Larry S. Sherman, et al.. (2007). The Role of CD44 Splice Variants in Human Metastatic Cancer. Novartis Foundation symposium. 189. 142–156. 4 indexed citations

Wallach‐Dayan, Shulamit B., Valentin Grabovsky, Jürgen Moll, et al.. (2001). CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. Journal of Cell Science. 114(19). 3463–3477. 38 indexed citations

10.

Khaldoyanidi, Sophia K., Jürgen Moll, Svetlana Karakhanova, Peter Herrlich, & Helmut Ponta. (1999). Hyaluronate-Enhanced Hematopoiesis: Two Different Receptors Trigger the Release of Interleukin-1β and Interleukin-6 From Bone Marrow Macrophages. Blood. 94(3). 940–949. 66 indexed citations

11.

Moll, Jürgen, et al.. (1998). Two different functions for CD44 proteins in human myelopoiesis.. Journal of Clinical Investigation. 102(5). 1024–1034. 45 indexed citations

12.

Kullmann, Michael, Jean Schneikert, Jürgen Moll, et al.. (1998). RAP46 Is a Negative Regulator of Glucocorticoid Receptor Action and Hormone-induced Apoptosis. Journal of Biological Chemistry. 273(23). 14620–14625. 122 indexed citations

13.

Weiss, Johannes M., Andreas C. Renkl, Thomas Ahrens, et al.. (1998). Activation-Dependent Modulation of Hyaluronate-Receptor Expression and of Hyaluronate-Avidity by Human Monocytes. Journal of Investigative Dermatology. 111(2). 227–232. 18 indexed citations

14.

Sleeman, Jonathan P., Kazuhiro Kondo, Jürgen Moll, Helmut Ponta, & Peter Herrlich. (1997). Variant Exons v6 and v7 Together Expand the Repertoire of Glycosaminoglycans Bound by CD44. Journal of Biological Chemistry. 272(50). 31837–31844. 74 indexed citations

15.

Moll, Jürgen, et al.. (1996). Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T cells. The Journal of Immunology. 156(6). 2085–2094. 32 indexed citations

16.

Dall, Peter, Armin Hekele, Hans Ikenberg, et al.. (1996). Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis. International Journal of Cancer. 69(2). 79–85. 29 indexed citations

17.

Moll, Jürgen, Peter Schmid, Gilles Sansig, & Herman van der Putten. (1996). The pattern of prothymosinα gene expression coincides with that ofmyc proto-oncogenes during mouse embryogenesis. The Histochemical Journal. 28(1). 45–52. 6 indexed citations

18.

König, Harald, Jürgen Moll, Helmut Ponta, & Peter Herrlich. (1996). Trans-acting factors regulate the expression of CD44 splice variants.. The EMBO Journal. 15(15). 4030–4039. 47 indexed citations

19.

Eibl, Robert H., Torsten Pietsch, Jürgen Moll, et al.. (1995). Expression of variant CD44 epitopes in human astrocytic brain tumors. Journal of Neuro-Oncology. 26(3). 165–170. 44 indexed citations

20.

Moll, Jürgen, Hermann Eibel, Peter Schmid, et al.. (1992). Thymic hyperplasia in transgenic mice caused by immortal epithelial cells expressing c‐kit ligand. European Journal of Immunology. 22(6). 1587–1594. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact